Ayurveda formulations: A roadmap to address the safety concerns.
作者信息
Rastogi Sanjeev
机构信息
State Ayurvedic College and Hospital, Lucknow, 226003, India.
出版信息
J Ayurveda Integr Med. 2018 Jan-Mar;9(1):81-82. doi: 10.1016/j.jaim.2018.02.002. Epub 2018 Mar 13.
Abstract
摘要
相似文献
1
Ayurveda formulations: A roadmap to address the safety concerns.
J Ayurveda Integr Med. 2018 Jan-Mar;9(1):81-82. doi: 10.1016/j.jaim.2018.02.002. Epub 2018 Mar 13.
2
Ayurveda formulations: A roadmap to address the safety concerns.
J Ayurveda Integr Med. 2017 Oct-Dec;8(4):279-282. doi: 10.1016/j.jaim.2017.08.010. Epub 2017 Nov 7.
3
Need for comprehensive standardization strategies for marketed Ayurveda formulations.
J Ayurveda Integr Med. 2018 Oct-Dec;9(4):312-315. doi: 10.1016/j.jaim.2018.09.002. Epub 2018 Dec 11.
4
Development of Ayurveda - Tradition to trend.
J Ethnopharmacol. 2017 Feb 2;197:10-24. doi: 10.1016/j.jep.2016.09.024. Epub 2016 Sep 12.
5
Toxicity of Ayurveda medicines and safety concerns: The need to revive the branch of toxicology in Ayurveda.
Anc Sci Life. 2014 Jul-Sep;34(1):1-2. doi: 10.4103/0257-7941.150761.
6
Profiling and determination of phenolic compounds in Indian marketed hepatoprotective polyherbal formulations and their comparative evaluation.
J Ayurveda Integr Med. 2018 Jan-Mar;9(1):3-12. doi: 10.1016/j.jaim.2016.12.006. Epub 2017 Dec 1.
7
Evaluation of package inserts of Ayurveda drug formulations from Mumbai city.
Ayu. 2015 Oct-Dec;36(4):370-374. doi: 10.4103/0974-8520.190694.
8
Changing scenario for promotion and development of Ayurveda--way forward.
J Ethnopharmacol. 2012 Sep 28;143(2):424-34. doi: 10.1016/j.jep.2012.07.036. Epub 2012 Aug 2.
9
Dosha phenotype specific Ayurveda intervention ameliorates asthma symptoms through cytokine modulations: Results of whole system clinical trial.
J Ethnopharmacol. 2017 Feb 2;197:110-117. doi: 10.1016/j.jep.2016.07.071. Epub 2016 Jul 26.
10
Do Ayurveda drugs induce liver injury?
World J Hepatol. 2018 Mar 27;10(3):400-401. doi: 10.4254/wjh.v10.i3.400.
引用本文的文献
1
Chemical Compositions of Metals in Bhasmas and Tibetan Zuotai Are a Major Determinant of Their Therapeutic Effects and Toxicity.
Evid Based Complement Alternat Med. 2019 Jan 10;2019:1697804. doi: 10.1155/2019/1697804. eCollection 2019.
2
Safety in Ayurveda: Need to bring the house in order.
Indian J Gastroenterol. 2018 Jul;37(4):374-375. doi: 10.1007/s12664-018-0883-4. Epub 2018 Aug 30.
本文引用的文献
1
Development and pilot testing of a prescription quality index for Ayurveda.
J Ayurveda Integr Med. 2019 Oct-Dec;10(4):277-283. doi: 10.1016/j.jaim.2017.02.008. Epub 2017 Nov 7.
2
Ayurveda formulations: A roadmap to address the safety concerns.
J Ayurveda Integr Med. 2017 Oct-Dec;8(4):279-282. doi: 10.1016/j.jaim.2017.08.010. Epub 2017 Nov 7.
3
Assessing the Ayurvedic prescribing trends on the basis of WHO drug use indicators.
J Ayurveda Integr Med. 2019 Jan-Mar;10(1):12-17. doi: 10.1016/j.jaim.2017.06.010. Epub 2017 Nov 4.
4
Urticarial rashes following guggulu intake: A case report.
J Ayurveda Integr Med. 2017 Jul-Sep;8(3):205-206. doi: 10.1016/j.jaim.2017.04.004. Epub 2017 Aug 18.
5
Ayurveda in critical care: Illustrating Ayurvedic intervention in a case of hepatic encephalopathy.
Ayu. 2011 Jul;32(3):345-8. doi: 10.4103/0974-8520.93911.
6
Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation.
J Ethnopharmacol. 1992 Jan;35(3):285-8. doi: 10.1016/0378-8741(92)90026-n.
Zotero 插件